Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuroleptic malignant syndrome--a case report].

M Lanczik1, J Fritze

  • 1Psychiatrische Klinik, Universität Füchsleinstr, Würzburg.

Psychiatrische Praxis
|May 1, 1992
PubMed
Summary

Malignant neuroleptic syndrome with urinary retention occurred during fluphenazine and prothipendyl treatment. Early recognition and drug cessation led to remission, with clozapine later tolerated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Telephone coaching for depression].

Der Nervenarzt·2017
Same author

The QT interval and the atypical antipsychotic, sertindole.

International journal of psychiatry in clinical practice·2014
Same author

Nimodipine and flunarizine in alcohol withdrawal: an open study.

Journal of psychopharmacology (Oxford, England)·2012
Same author

[Preoperative anemia in orthopedic surgery: clinical impact, diagnostics and treatment].

Der Orthopade·2011
Same author

Neuropeptide S receptor gene -- converging evidence for a role in panic disorder.

Molecular psychiatry·2010
Same author

[Do individuals with substance use disorders find information for crisis intervention and suicide prevention resources on the Internet?].

Der Nervenarzt·2010

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Pharmacology

Background:

  • Neuroleptic medications are standard treatments for psychosis.
  • Antipsychotic drugs, including fluphenazine and prothipendyl, carry risks of adverse effects.
  • Understanding rare but severe syndromes is crucial for patient safety.

Observation:

  • A case of malignant neuroleptic syndrome (MNS) with urinary retention is presented.
  • The patient was a mentally disabled individual with psychosis undergoing treatment.
  • Symptoms emerged during treatment with fluphenazine and prothipendyl.

Findings:

  • Prompt identification of MNS and immediate discontinuation of neuroleptic medication resulted in spontaneous recovery.
  • The patient subsequently tolerated clozapine treatment without adverse events.
  • This suggests clozapine may be a safer alternative in certain high-risk patients.

Implications:

  • Early recognition and management are key to resolving MNS.
  • This case highlights the importance of vigilant monitoring for severe adverse drug reactions.
  • Clozapine appears to be a viable option for patients who have experienced MNS with other antipsychotics.

Related Experiment Videos